HIWU advisory re: Adenosine, Hemo 15 — use and possession are prohibited

Unedited horsemen’s advisory from HIWU (Horseracing Integrity & Welfare Unit):

JUN 11, 2025

In recent months, HIWU has adjudicated several cases under the Anti-Doping and Medication Control (ADMC) Program related to adenosine, a vasodilator, and Hemo 15, a foreign product that lacks FDA approval. Neither substance has any valid veterinary use in the racehorse.

Both substances are categorized as an S0 Non-Approved Banned Substance and therefore are prohibited from Use in a Covered Horse or Possession by a Covered Person at all times. Hemo 15 and any compounded product mimicking Hemo 15, as well as any products containing adenosine, adenosine monophosphate (AMP), or adenosine triphosphate (ATP)* should be disposed of immediately.

As a reminder, the Presence, Use, Administration, Possession, or Trafficking of any Banned Substance is subject to a period of Ineligibility of up to two years, a fine of up to $25,000, the disqualification of race results (as applicable), and public disclosure.

Horsemen or veterinarians with questions should reach out to sciencesupport@hiwu.org.

*Adenosine is also a component of AMP and ATP.

Link to advisory on HIWU website

Jennie Rees is a communications and advocacy specialist in the horse industry who spent 32 years covering horse racing for The (Louisville) Courier-Journal before taking a corporate buyout. In addition to handling communications for the Kentucky HBPA, Rees serves as a consultant to the National HBPA. Other projects include the Preakness Stakes, Indiana Grand’s Indiana Derby Week and work for various HBPA affiliates and horsemen’s associations.